Immunocore Holdings plc — Director's Dealing 2024

May 28, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immunocore Holdings plc (IMCR)
CIK: 0001671927
Period of Report: 2024-05-23

Reporting Person: Bell John Irving (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-23	Share Option (Right to Buy)	$50.47	A	14534	Acquired	2034-05-22	Ordinary Shares (14534)	Direct

Footnotes

F1: The shares subject to the option award shall vest at the earlier of (i) May 23, 2025 and (ii) the day immediately prior to the date of our next annual general meeting, subject to the Reporting Person's continuous service through such vesting date.